Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study
Clinical trial NCT04993625 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04993625
- Sponsor
- Jeong Eon Lee
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2028-12-31
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.